Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QAV8
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 2 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 2 |
GO:0006468 | protein phosphorylation | 5 | 8 |
GO:0006793 | phosphorus metabolic process | 3 | 8 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 8 |
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0006950 | response to stress | 2 | 2 |
GO:0006974 | DNA damage response | 4 | 2 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 4 | 2 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0007346 | regulation of mitotic cell cycle | 5 | 2 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0010564 | regulation of cell cycle process | 5 | 2 |
GO:0010948 | negative regulation of cell cycle process | 6 | 2 |
GO:0016310 | phosphorylation | 5 | 8 |
GO:0019538 | protein metabolic process | 3 | 8 |
GO:0022402 | cell cycle process | 2 | 2 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 2 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0036211 | protein modification process | 4 | 8 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 8 |
GO:0043412 | macromolecule modification | 4 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 6 | 2 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 5 | 2 |
GO:0045786 | negative regulation of cell cycle | 5 | 2 |
GO:0045930 | negative regulation of mitotic cell cycle | 6 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0051726 | regulation of cell cycle | 4 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 8 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 2 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 2 |
GO:1903047 | mitotic cell cycle process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 8 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0004672 | protein kinase activity | 3 | 8 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 2 |
GO:0005488 | binding | 1 | 8 |
GO:0005524 | ATP binding | 5 | 8 |
GO:0016301 | kinase activity | 4 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 8 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 8 |
GO:0017076 | purine nucleotide binding | 4 | 8 |
GO:0030554 | adenyl nucleotide binding | 5 | 8 |
GO:0032553 | ribonucleotide binding | 3 | 8 |
GO:0032555 | purine ribonucleotide binding | 4 | 8 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 8 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 8 |
GO:0036094 | small molecule binding | 2 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043168 | anion binding | 3 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:0097367 | carbohydrate derivative binding | 2 | 8 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 8 |
GO:1901265 | nucleoside phosphate binding | 3 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 356 | 360 | PF00656 | 0.477 |
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.742 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.676 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.647 |
CLV_PCSK_KEX2_1 | 333 | 335 | PF00082 | 0.438 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.676 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.647 |
CLV_PCSK_PC1ET2_1 | 333 | 335 | PF00082 | 0.244 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 465 | 469 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 480 | 484 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 512 | 516 | PF00082 | 0.607 |
CLV_PCSK_SKI1_1 | 518 | 522 | PF00082 | 0.648 |
CLV_Separin_Metazoa | 246 | 250 | PF03568 | 0.329 |
DEG_APCC_DBOX_1 | 155 | 163 | PF00400 | 0.477 |
DEG_APCC_DBOX_1 | 194 | 202 | PF00400 | 0.405 |
DEG_APCC_DBOX_1 | 488 | 496 | PF00400 | 0.352 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.736 |
DEG_SPOP_SBC_1 | 340 | 344 | PF00917 | 0.399 |
DEG_SPOP_SBC_1 | 42 | 46 | PF00917 | 0.772 |
DOC_ANK_TNKS_1 | 89 | 96 | PF00023 | 0.596 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 108 | 117 | PF00134 | 0.244 |
DOC_CYCLIN_yCln2_LP_2 | 9 | 15 | PF00134 | 0.638 |
DOC_MAPK_gen_1 | 453 | 463 | PF00069 | 0.399 |
DOC_MAPK_MEF2A_6 | 323 | 331 | PF00069 | 0.405 |
DOC_PP2B_LxvP_1 | 107 | 110 | PF13499 | 0.477 |
DOC_PP4_FxxP_1 | 161 | 164 | PF00568 | 0.487 |
DOC_SPAK_OSR1_1 | 90 | 94 | PF12202 | 0.611 |
DOC_USP7_MATH_1 | 180 | 184 | PF00917 | 0.544 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.405 |
DOC_USP7_MATH_1 | 514 | 518 | PF00917 | 0.698 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.662 |
DOC_WW_Pin1_4 | 373 | 378 | PF00397 | 0.405 |
DOC_WW_Pin1_4 | 406 | 411 | PF00397 | 0.324 |
DOC_WW_Pin1_4 | 525 | 530 | PF00397 | 0.586 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.555 |
LIG_14-3-3_CanoR_1 | 147 | 155 | PF00244 | 0.352 |
LIG_14-3-3_CanoR_1 | 21 | 26 | PF00244 | 0.726 |
LIG_14-3-3_CanoR_1 | 465 | 473 | PF00244 | 0.463 |
LIG_14-3-3_CanoR_1 | 480 | 485 | PF00244 | 0.338 |
LIG_APCC_ABBAyCdc20_2 | 315 | 321 | PF00400 | 0.341 |
LIG_BRCT_BRCA1_1 | 183 | 187 | PF00533 | 0.621 |
LIG_BRCT_BRCA1_1 | 527 | 531 | PF00533 | 0.743 |
LIG_EH_1 | 290 | 294 | PF12763 | 0.352 |
LIG_FHA_1 | 522 | 528 | PF00498 | 0.653 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.455 |
LIG_FHA_2 | 163 | 169 | PF00498 | 0.539 |
LIG_FHA_2 | 186 | 192 | PF00498 | 0.660 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.386 |
LIG_FHA_2 | 292 | 298 | PF00498 | 0.396 |
LIG_FHA_2 | 334 | 340 | PF00498 | 0.247 |
LIG_FHA_2 | 354 | 360 | PF00498 | 0.394 |
LIG_GBD_Chelix_1 | 113 | 121 | PF00786 | 0.244 |
LIG_Integrin_isoDGR_2 | 141 | 143 | PF01839 | 0.477 |
LIG_LIR_Apic_2 | 158 | 164 | PF02991 | 0.387 |
LIG_LIR_Apic_2 | 409 | 415 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 175 | 180 | PF02991 | 0.404 |
LIG_LIR_Gen_1 | 184 | 193 | PF02991 | 0.578 |
LIG_LIR_Gen_1 | 280 | 286 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 175 | 179 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 184 | 190 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 280 | 285 | PF02991 | 0.322 |
LIG_NRBOX | 438 | 444 | PF00104 | 0.405 |
LIG_Pex14_2 | 135 | 139 | PF04695 | 0.405 |
LIG_SH2_NCK_1 | 412 | 416 | PF00017 | 0.405 |
LIG_SH2_SRC | 311 | 314 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 378 | 382 | PF00017 | 0.405 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.697 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 311 | 314 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 444 | 447 | PF00017 | 0.405 |
LIG_SH3_1 | 29 | 35 | PF00018 | 0.686 |
LIG_SH3_1 | 526 | 532 | PF00018 | 0.667 |
LIG_SH3_3 | 29 | 35 | PF00018 | 0.746 |
LIG_SH3_3 | 448 | 454 | PF00018 | 0.353 |
LIG_SH3_3 | 526 | 532 | PF00018 | 0.638 |
LIG_SUMO_SIM_anti_2 | 468 | 474 | PF11976 | 0.399 |
LIG_SUMO_SIM_par_1 | 519 | 524 | PF11976 | 0.645 |
LIG_TRAF2_1 | 165 | 168 | PF00917 | 0.626 |
LIG_TRAF2_1 | 233 | 236 | PF00917 | 0.373 |
LIG_TRAF2_1 | 426 | 429 | PF00917 | 0.282 |
LIG_TRFH_1 | 196 | 200 | PF08558 | 0.405 |
LIG_TRFH_1 | 73 | 77 | PF08558 | 0.507 |
LIG_WW_3 | 453 | 457 | PF00397 | 0.399 |
MOD_CDK_SPxxK_3 | 31 | 38 | PF00069 | 0.728 |
MOD_CK1_1 | 185 | 191 | PF00069 | 0.597 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.726 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.358 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.609 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.607 |
MOD_CK2_1 | 230 | 236 | PF00069 | 0.431 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.221 |
MOD_CK2_1 | 291 | 297 | PF00069 | 0.405 |
MOD_CK2_1 | 333 | 339 | PF00069 | 0.390 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.722 |
MOD_CK2_1 | 527 | 533 | PF00069 | 0.616 |
MOD_Cter_Amidation | 141 | 144 | PF01082 | 0.405 |
MOD_DYRK1A_RPxSP_1 | 31 | 35 | PF00069 | 0.569 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.244 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.574 |
MOD_GlcNHglycan | 264 | 268 | PF01048 | 0.386 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.466 |
MOD_GlcNHglycan | 388 | 391 | PF01048 | 0.477 |
MOD_GlcNHglycan | 429 | 433 | PF01048 | 0.310 |
MOD_GlcNHglycan | 447 | 450 | PF01048 | 0.352 |
MOD_GlcNHglycan | 506 | 509 | PF01048 | 0.589 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.359 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.327 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.659 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.657 |
MOD_GSK3_1 | 339 | 346 | PF00069 | 0.448 |
MOD_GSK3_1 | 349 | 356 | PF00069 | 0.347 |
MOD_GSK3_1 | 402 | 409 | PF00069 | 0.399 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.615 |
MOD_GSK3_1 | 480 | 487 | PF00069 | 0.477 |
MOD_GSK3_1 | 521 | 528 | PF00069 | 0.583 |
MOD_N-GLC_1 | 135 | 140 | PF02516 | 0.316 |
MOD_N-GLC_1 | 463 | 468 | PF02516 | 0.419 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.516 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.405 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.386 |
MOD_NEK2_1 | 401 | 406 | PF00069 | 0.411 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.564 |
MOD_NEK2_1 | 463 | 468 | PF00069 | 0.431 |
MOD_NEK2_1 | 521 | 526 | PF00069 | 0.643 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.560 |
MOD_NEK2_2 | 237 | 242 | PF00069 | 0.405 |
MOD_PIKK_1 | 484 | 490 | PF00454 | 0.361 |
MOD_PKA_1 | 333 | 339 | PF00069 | 0.361 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.356 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.358 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.730 |
MOD_PKA_2 | 230 | 236 | PF00069 | 0.466 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.677 |
MOD_PKA_2 | 333 | 339 | PF00069 | 0.390 |
MOD_PKA_2 | 488 | 494 | PF00069 | 0.405 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.527 |
MOD_PKB_1 | 19 | 27 | PF00069 | 0.694 |
MOD_PKB_1 | 39 | 47 | PF00069 | 0.640 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.405 |
MOD_Plk_1 | 463 | 469 | PF00069 | 0.477 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.392 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.259 |
MOD_Plk_4 | 157 | 163 | PF00069 | 0.341 |
MOD_Plk_4 | 360 | 366 | PF00069 | 0.373 |
MOD_Plk_4 | 456 | 462 | PF00069 | 0.403 |
MOD_Plk_4 | 468 | 474 | PF00069 | 0.393 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.663 |
MOD_ProDKin_1 | 373 | 379 | PF00069 | 0.405 |
MOD_ProDKin_1 | 406 | 412 | PF00069 | 0.324 |
MOD_ProDKin_1 | 525 | 531 | PF00069 | 0.585 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.572 |
MOD_SUMO_for_1 | 17 | 20 | PF00179 | 0.623 |
MOD_SUMO_for_1 | 322 | 325 | PF00179 | 0.352 |
MOD_SUMO_for_1 | 390 | 393 | PF00179 | 0.399 |
MOD_SUMO_rev_2 | 316 | 324 | PF00179 | 0.405 |
MOD_SUMO_rev_2 | 366 | 375 | PF00179 | 0.405 |
MOD_SUMO_rev_2 | 46 | 53 | PF00179 | 0.730 |
TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.477 |
TRG_ER_diArg_1 | 229 | 232 | PF00400 | 0.399 |
TRG_ER_diArg_1 | 29 | 32 | PF00400 | 0.696 |
TRG_ER_diArg_1 | 37 | 39 | PF00400 | 0.759 |
TRG_Pf-PMV_PEXEL_1 | 299 | 304 | PF00026 | 0.405 |
TRG_Pf-PMV_PEXEL_1 | 7 | 11 | PF00026 | 0.684 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P787 | Leptomonas seymouri | 24% | 100% |
A0A0N1HTF0 | Leptomonas seymouri | 26% | 85% |
A0A0N1HZY0 | Leptomonas seymouri | 58% | 90% |
A0A0N1I1M7 | Leptomonas seymouri | 27% | 83% |
A0A0S4IZ14 | Bodo saltans | 40% | 90% |
A0A0S4J1U0 | Bodo saltans | 25% | 73% |
A0A0S4J757 | Bodo saltans | 25% | 99% |
A0A0S4JI27 | Bodo saltans | 25% | 75% |
A0A3Q8IAQ1 | Leishmania donovani | 28% | 100% |
A0A3Q8INQ4 | Leishmania donovani | 26% | 100% |
A0A3S5H5G0 | Leishmania donovani | 23% | 100% |
A0A3S5H5U5 | Leishmania donovani | 22% | 100% |
A0A3S7WTN9 | Leishmania donovani | 23% | 100% |
A0A3S7WV74 | Leishmania donovani | 26% | 85% |
A0A3S7WVR6 | Leishmania donovani | 24% | 87% |
A0A3S7WY10 | Leishmania donovani | 93% | 99% |
A0A3S7X8Z8 | Leishmania donovani | 27% | 100% |
A4H459 | Leishmania braziliensis | 24% | 100% |
A4H9X1 | Leishmania braziliensis | 27% | 85% |
A4HD79 | Leishmania braziliensis | 80% | 99% |
A4HHE4 | Leishmania braziliensis | 27% | 91% |
A4HSE2 | Leishmania infantum | 23% | 100% |
A4HWP5 | Leishmania infantum | 23% | 100% |
A4HYH7 | Leishmania infantum | 24% | 87% |
A4HZW8 | Leishmania infantum | 28% | 100% |
A4I1T4 | Leishmania infantum | 26% | 100% |
A4IB02 | Leishmania infantum | 27% | 100% |
A5A7I7 | Solanum tuberosum | 27% | 97% |
C9ZMG9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 83% |
C9ZWL6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 84% |
E9ADZ1 | Leishmania major | 27% | 91% |
E9AET0 | Leishmania major | 28% | 100% |
E9AG71 | Leishmania infantum | 22% | 100% |
E9AGR6 | Leishmania infantum | 26% | 85% |
E9AH34 | Leishmania infantum | 93% | 99% |
E9AKB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9ALU0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 92% |
E9AQF3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9ARW5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 86% |
E9AWL2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 99% |
E9AXW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
E9B5Y5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
O43293 | Homo sapiens | 28% | 100% |
O61267 | Drosophila melanogaster | 29% | 100% |
O94547 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 93% |
O96017 | Homo sapiens | 30% | 99% |
P00518 | Oryctolagus cuniculus | 27% | 100% |
P07934 | Mus musculus | 27% | 100% |
P13286 | Rattus norvegicus | 27% | 100% |
P34101 | Dictyostelium discoideum | 27% | 90% |
P39009 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 100% |
P93759 | Arabidopsis thaliana | 27% | 100% |
Q09170 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |
Q10292 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |
Q12701 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 91% |
Q16816 | Homo sapiens | 26% | 100% |
Q2QMI0 | Oryza sativa subsp. japonica | 29% | 100% |
Q42438 | Arabidopsis thaliana | 30% | 100% |
Q4Q9K2 | Leishmania major | 26% | 100% |
Q4QD63 | Leishmania major | 24% | 87% |
Q4QDK7 | Leishmania major | 26% | 85% |
Q4QF23 | Leishmania major | 24% | 100% |
Q4QJJ0 | Leishmania major | 23% | 100% |
Q54BF0 | Dictyostelium discoideum | 25% | 91% |
Q54MH0 | Dictyostelium discoideum | 30% | 72% |
Q54VI1 | Dictyostelium discoideum | 27% | 76% |
Q5XHI9 | Xenopus laevis | 27% | 78% |
Q6C3J2 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 26% | 100% |
Q8BW96 | Mus musculus | 30% | 100% |
Q8IU85 | Homo sapiens | 29% | 100% |
Q9U1Y5 | Caenorhabditis elegans | 28% | 100% |
Q9Z265 | Mus musculus | 31% | 99% |
Q9ZV15 | Arabidopsis thaliana | 27% | 92% |
V5B7L8 | Trypanosoma cruzi | 27% | 84% |
V5BP88 | Trypanosoma cruzi | 25% | 100% |